CN101085187A - 百合药酒 - Google Patents
百合药酒 Download PDFInfo
- Publication number
- CN101085187A CN101085187A CN 200710069448 CN200710069448A CN101085187A CN 101085187 A CN101085187 A CN 101085187A CN 200710069448 CN200710069448 CN 200710069448 CN 200710069448 A CN200710069448 A CN 200710069448A CN 101085187 A CN101085187 A CN 101085187A
- Authority
- CN
- China
- Prior art keywords
- bulbus lilii
- oryza glutinosa
- lilii
- little
- aging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000234435 Lilium Species 0.000 title claims abstract description 6
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 17
- 240000007594 Oryza sativa Species 0.000 claims abstract description 13
- 239000003814 drug Substances 0.000 claims abstract description 8
- 241000628997 Flos Species 0.000 claims description 14
- 238000000855 fermentation Methods 0.000 claims description 14
- 230000004151 fermentation Effects 0.000 claims description 14
- 230000032683 aging Effects 0.000 claims description 12
- 229930006000 Sucrose Natural products 0.000 claims description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 7
- 238000010025 steaming Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000005352 clarification Methods 0.000 claims description 5
- 235000021395 porridge Nutrition 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 210000004072 lung Anatomy 0.000 abstract description 13
- 206010011224 Cough Diseases 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000000616 Hemoptysis Diseases 0.000 abstract description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 5
- 230000001914 calming effect Effects 0.000 abstract description 5
- 206010022437 insomnia Diseases 0.000 abstract description 5
- 235000009566 rice Nutrition 0.000 abstract description 5
- 230000002936 tranquilizing effect Effects 0.000 abstract description 5
- 206010007247 Carbuncle Diseases 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 3
- 230000008961 swelling Effects 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- 239000000463 material Substances 0.000 description 10
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000001093 anti-cancer Effects 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000209094 Oryza Species 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- 206010057315 Daydreaming Diseases 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 201000005569 Gout Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229960001338 colchicine Drugs 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010010144 Completed suicide Diseases 0.000 description 2
- 208000012895 Gastric disease Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 231100000739 chronic poisoning Toxicity 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 208000018556 stomach disease Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- NNJPGOLRFBJNIW-HNNXBMFYSA-N (-)-demecolcine Chemical compound C1=C(OC)C(=O)C=C2[C@@H](NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-HNNXBMFYSA-N 0.000 description 1
- IECBDTGWSQNQID-JGVFFNPUSA-N (1r,5s)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-7-one Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2=O IECBDTGWSQNQID-JGVFFNPUSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- YFVGIJBUXMQFOF-PJOVQGMDSA-N 5-hydroxy-2-(4-methoxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one Chemical compound C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 YFVGIJBUXMQFOF-PJOVQGMDSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- KRFYMPRAIPKTAI-UHFFFAOYSA-N Brownioside Natural products CC1OC(OC2C(O)C(O)C(CO)OC2OC3CCC4(C)C5CCC6(C)C(CC7OC8(CCC(COC(=O)CC(C)(O)CC(=O)O)CO8)C(C)C67)C5CC=C4C3)C(O)C(O)C1O KRFYMPRAIPKTAI-UHFFFAOYSA-N 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- IECBDTGWSQNQID-UHFFFAOYSA-N Chrysanthenon Natural products CC1=CCC2C(C)(C)C1C2=O IECBDTGWSQNQID-UHFFFAOYSA-N 0.000 description 1
- IECBDTGWSQNQID-SFYZADRCSA-N Chrysanthenone Natural products CC1=CC[C@H]2C(C)(C)[C@@H]1C2=O IECBDTGWSQNQID-SFYZADRCSA-N 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- NNJPGOLRFBJNIW-UHFFFAOYSA-N Demecolcine Natural products C1=C(OC)C(=O)C=C2C(NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- YFVGIJBUXMQFOF-SAXLCNSLSA-N Linarin Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4ccc(OC)cc4)Oc3c2)O1)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 YFVGIJBUXMQFOF-SAXLCNSLSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- QBYFCXBVWQQXFH-UHFFFAOYSA-N acaciin Natural products COc1ccc(cc1)C2=CC(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4OC6OCC(O)C(O)C6O)cc3O2 QBYFCXBVWQQXFH-UHFFFAOYSA-N 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 231100000570 acute poisoning Toxicity 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 235000020051 akvavit Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229960005052 demecolcine Drugs 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000000517 effect on sleep Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 230000001527 leucocytic effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 231100000017 mucous membrane irritation Toxicity 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 201000008261 skin carcinoma Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 208000024719 uterine cervix neoplasm Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种中药药酒的技术领域,主要是由百合花,适量的糯米和小曲等原料组成,本发明是以润肺止咳、宁心安神的百合花为理论治疗依据的,尤其是对治疗肺燥止咳、咳血、精神恍惚、失眠心烦、痈肿等病症有显著的效果,经临床实验证明,本发明无任何副作用且饮用方便,适合四季饮用。
Description
技术领域
本发明涉及一种治疗肺燥止咳、咳血、精神恍惚、失眠心烦、痈肿等病症的药物组合及制备方法,尤其是润肺止咳、宁心安神的具有保健疗效的药酒。
背景技术
酒的化学成分是乙醇,在消化道内不需要消化即可吸收,吸收快而且完全。一般在胃中吸收20%,其余80%被十二指肠和空肠吸收。
中国特有的一种蒸馏酒。由淀粉或糖质原料制成酒醅或发酵醪经蒸馏而得。又称烧酒、老白干、烧刀子等。酒质无色(或微黄)透明,气味芳香纯正,入口绵甜爽净,酒精含量较高,经贮存老熟后,具有以酯类为主体的复合香味。
酒中会含有多量的甲醇,甲醇对人体的毒性作用较大,4-10克即可引起严重中毒。尤其是甲醇的氧化物甲酸和甲醛,毒性更大于甲醇,甲酸的毒性比甲醇大6倍,而甲醛的毒性比甲醇大30倍。白酒饮用过多,甲醇在体内有积蓄作用,不易排出体外,它在体内的代谢产物是甲酸和甲醛,所以极少量的甲醇也能引起慢性中毒。发生急性中毒时,会出现头痛、恶心、胃部疼痛、视力模糊等症状,继续发展可出现呼吸困难,呼吸中枢麻痹,昏迷甚至死亡。慢性中毒主要表现为粘膜刺激症状、眩晕、昏睡、头痛、消化障碍、视力模糊和耳鸣等,以致双目失明。
白酒多喝容易伤身体,市场上的药酒普遍的特点是疗效不显著,口感不好。
发明内容
本发明的目的是为其提供一种治疗效果显著、无副作用且制作简单的保健药酒。
一种治疗肺燥止咳、咳血、精神恍惚、失眠心烦、痈肿等病症的药酒,所提供技术方案是:取1000克百合花,适量的糯米和小曲,首先将百合烘干碾成粗粉状;再将糯米淘洗干净,放入水中浸泡,将小曲粉碎;再将百合化分和粉碎的小曲放入糯米中搅拌均匀,再蒸煮至干粥状,冷却至30度,将其压榨至浆状加1.2%~2%的白砂糖进行糖化;放入果胶酶后倒入陶器中发酵;发酵温度保持在27~35度;两周后,发酵完成;将其压榨至浆状加1.2%~2%的白砂糖进行糖化;滤渣陈酿,陈酿期间不可接触空气,保证酒质的醇厚;澄清后即可装瓶。
为实现本发明所提供的制备步骤如下:
1、选料。所选材料必须是成熟、无病害的材料。
2、备料。
A、将百合烘干碾成粗粉状;
B、大米淘洗干净,用水浸泡令其发胀;
C、将小曲粉碎;
3、蒸煮。将百合粗粉和粉碎了的小曲放入大米中搅拌均匀,进行蒸煮,煮至干粥状再冷却至30度;
4、发酵。加入果胶酶搅拌均匀后倒入陶器中发酵,发酵温度需控制在28~35度之间,且要保持温度恒定,若温度上升过快可以搅拌降温,发酵时间2周;
5、压榨、糖化。发酵完全的浆进行压榨后,加入1.2%~2%的白砂糖进行糖化;
6、陈酿。将压榨后的药酒放入橡桶中进行陈酿,可保证药酒的醇厚品质和美味;
7、澄清。是酿制药酒的最后一个步骤,可增加药酒的透明度。
百合是世界名花,也是我国的传统花卉。又名喇叭筒、百合蒜,属百合科多年生草本植物。百合入药始载于汉朝《神农本草经》,中医认为其性平味甘微苦,无毒,入心、肺二经。能养阴清热,润肺止渴,宁心安神,治肺结核久咳、阴虚咳血、潮热肺痈、热病后余热未清、虚烦惊悸、神志恍惚、失眠多梦、脚气浮肿等症;现代医学研究发现,百合除了含蛋白质、淀粉、糖类、维生素、氨基酸、钙、磷、铁外,还含百合甙A、百合甙B,特别含有秋水仙碱、秋水仙胺等类似植物碱,能抑制癌细胞增生。临床用于白血病、皮肤癌、鼻咽癌、乳腺癌、宫颈癌,均有明显疗效。若服食清蒸百合,还可治胃病、肝病、贫血。
百合在药用方面的作用有:
百合性味甘,微苦,平。入心、肺二经。有补中益气,滋养强壮,安心利胆,润肺止咳,轻身延年之功,用于老年人肺虚咳嗽,虚烦惊悸,失眼多梦,支气管哮喘,慢性肾炎,高血压等。现代研究,其化学成份有淀粉、蔗糖、蛋白质、脂肪、胡萝卜素、泛酸、维生素(C、B1、B2)、钙、铁、磷、钾等。其药理作用:百合水提取物有增强免疫功能,抑制癌细胞增生;可增加肺灌流量,有止咳平喘作用,具有雌激素样活性,对老年人雌激素功能低下很有裨益。百合为甘滑降泄之品,对风寒咳嗽,中寒便溏者忌用。百合为补益之品,古有“渗利和中之美药”的誉称,用于安养五脏,“补虚损”,“滋养强壮”等。
随着对百合化学成分及药理作用的深入研究,百合的药效范围变得更加广泛,其主要的功效有以下几方面。
●抗癌
百合中含有许多具有活性的生物碱,在1微克/毫升浓度时,进行体外组织培养,能抑制癌细胞增殖,有明显的抗癌作用。现代药理研究证实,百合对实验性小鼠肉瘤-180、宫颈瘤-14有较强的抑制作用。研究证实,食用百合有助于增强体质,抑制肿瘤细胞的生长,缓解放疗反应,如加薏米可提高抗癌能力。
●增强免疫功能
百合中的蛋白质、氨基酸和多糖可提高人体的免疫力。服用百合水提取液,每日两次,连续10天,能显著增强机体活力、抑制2,4-二硝基氯苯所致迟发型过敏反应,同时外周血液白细胞数明显增加。将百合多糖250微克/毫升与淋巴细胞共同培养,可显著促进DNA和RNA的合成,同时淋巴细胞存活率也增加。
●镇静催眠
百合中含有百合苷,有镇静和催眠的作用。试验证明,每晚睡眠前服用百合汤,有明显改善睡眠作用,可提高睡眠质量。
●痛风发作的辅助治疗
百合含有丰富的秋水仙碱,可用于痛风发作关节痛的辅助治疗。秋水仙碱不影响尿酸的排泄,而是通过抑制白细胞的活动及吞噬细胞的作用,减少尿酸形成的尿酸盐沉积,起到迅速减轻炎症,有效止痛的作用,对痛风发作所致的急性关节炎症有辅助治疗作用。
●抗疲劳、抗应激
百合中含有多种营养物质,如矿物质、维生素等,这些物质能促进机体营养代谢,使机体抗疲劳、耐缺氧能力增强,同时能清除体内的有害物质,延缓衰老。
●保护胃黏膜
百合中含有果胶及磷脂类物质,服用后可保护胃黏膜,治疗胃病。
本发明对治疗肺燥止咳、咳血、精神恍惚、失眠心烦、痈肿等病症有着显著的疗效,无任何的副作用,具有润肺止咳、宁心安神的功效,与现有的治疗此类病症的技术相比,本发明无须进行药物和手术等费用昂贵的治疗方式,而且长期服用还可以达到保健的效果。
具体实施方式
在具体实施过程中,取1000克百合花,适量的糯米和小曲,首先将百合烘干碾成粗粉状;再将糯米淘洗干净,放入水中浸泡,将小曲粉碎;再将百合化分和粉碎的小曲放入糯米中搅拌均匀,再蒸煮至干粥状,冷却至30度,将其压榨至浆状加1.2%~2%的白砂糖进行糖化;放入果胶酶后倒入陶器中发酵;发酵温度保持在27~35度;两周后,发酵完成;将其压榨至浆状加1.2%~2%的白砂糖进行糖化;滤渣陈酿,陈酿期间不可接触空气,保证酒质的醇厚;澄清后即可装瓶。
另外,还可以加入菊花,与百合一起酿造药酒。菊花,味甘苦,性微寒,它的药用价值古有记载。《本草纲目》中说菊花有清热解毒,平肝明目的功能。《神农本草经》记载,久服菊花“可利血气、轻身、耐老、延年。”现代科学经过分析,证明菊花中含有腺嘌呤、胆碱、水苏碱、菊酮蓝、黄酮类、维生素B以及香油烽、龙脑樟脑、菊油环酮、葡萄糖、刺槐甙等成份。因此,具有散热、祛风、降火解毒、清肝明目、安胃利脉、减肥降压、延年长寿等作用。
菊花在临床上使用十分广泛,用于多种疾病的治疗。其所含化学成分复杂,具有多种生物活性。
结合具体实施方案进行详细的说明
实施例一
配伍:1000克百合花,适量的糯米和小曲。
制备方法:
1、选料。所选材料必须是成熟、无病害的材料。
2、备料。
(1)将百合烘干碾成粗粉状;
(2)大米淘洗干净,用水浸泡令其发胀;
(3)将小曲粉碎;
3、蒸煮。将百合粗粉和粉碎了的小曲放入大米中搅拌均匀,进行蒸煮,煮至干粥状再冷却至30度;
4、发酵。加入果胶酶搅拌均匀后倒入陶器中发酵,发酵温度需控制在28~35度之间,且要保持温度恒定,若温度上升过快可以搅拌降温,发酵时间2周;
5、压榨、糖化。发酵完全的浆进行压榨后,加入1.2%~2%的白砂糖进行糖化;
6、陈酿。将压榨后的药酒放入橡桶中进行陈酿,可保证药酒的醇厚品质和美味;
7、澄清。是酿制药酒的最后一个步骤,可增加药酒的透明度。
实施例二
配伍:1000克百合花,800克菊花,适量的糯米和小曲/
制备方法同实施例一。
Claims (2)
1.一种百合药酒,其特征在于本发明由以下配方配比组成:取1000克百合花,适量的糯米和小曲,首先将百合烘干碾成粗粉状;再将糯米淘洗干净,放入水中浸泡,将小曲粉碎;再将百合化分和粉碎的小曲放入糯米中搅拌均匀,再蒸煮至干粥状,冷却至30度,将其压榨至浆状加1.2%~2%的白砂糖进行糖化;放入果胶酶后倒入陶器中发酵;发酵温度保持在27~35度;两周后,发酵完成;将其压榨至浆状加1.2%~2%的白砂糖进行糖化;滤渣陈酿,陈酿期间不可接触空气,保证酒质的醇厚;澄清后即可装瓶。
2.根据权利要求1所述,其特征是配方为1000克百合花,800克的菊花以及适量的糯米和小曲。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200710069448 CN101085187A (zh) | 2007-06-25 | 2007-06-25 | 百合药酒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200710069448 CN101085187A (zh) | 2007-06-25 | 2007-06-25 | 百合药酒 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101085187A true CN101085187A (zh) | 2007-12-12 |
Family
ID=38936472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200710069448 Pending CN101085187A (zh) | 2007-06-25 | 2007-06-25 | 百合药酒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101085187A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104263583A (zh) * | 2014-09-25 | 2015-01-07 | 四川国凤中科生物科技有限公司 | 一种蜂蜜百合花酒的酿制方法 |
CN108913428A (zh) * | 2018-07-19 | 2018-11-30 | 江苏高祖酒业有限公司 | 一种百合清香型白酒的制备方法 |
-
2007
- 2007-06-25 CN CN 200710069448 patent/CN101085187A/zh active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104263583A (zh) * | 2014-09-25 | 2015-01-07 | 四川国凤中科生物科技有限公司 | 一种蜂蜜百合花酒的酿制方法 |
CN108913428A (zh) * | 2018-07-19 | 2018-11-30 | 江苏高祖酒业有限公司 | 一种百合清香型白酒的制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
CN101278730B (zh) | 灵芝红景天口服液的制备方法 | |
CN106360540A (zh) | 一种怀姜糖膏及其生产工艺 | |
CN103484308A (zh) | 一种保健酒及其制备方法 | |
CN103815100B (zh) | 一种木瓜茶饮料及其制备方法 | |
CN105029606A (zh) | 茉莉花醋饮料的制备方法 | |
CN104256782B (zh) | 一种葛根山杞饮料及其制备方法 | |
CN101654642B (zh) | 一种蜂花蜜酒及其制备方法 | |
CN101669624A (zh) | 一种具有改善妇女贫血功能的中药八宝茶及其制备方法 | |
CN101085971B (zh) | 微发酵芹菜葡萄酒及其加工工艺 | |
CN102106577B (zh) | 天然有机可提高男性睡眠质量的饮料 | |
CN104673571A (zh) | 一种美容养颜sod葡萄酒及制备方法 | |
CN101955874B (zh) | 一种苦杏酒的酿造方法 | |
CN104232428A (zh) | 野菊花糯米酒及其制作方法 | |
CN106581292A (zh) | 龙族膏方及其制备方法 | |
CN105410243A (zh) | 一种四季养生保健茶 | |
CN101085187A (zh) | 百合药酒 | |
CN104774719A (zh) | 一种药食两用的养生酒及其制备方法 | |
CN104371894A (zh) | 菊花明目中药酒及制备方法 | |
CN106753952A (zh) | 具有啤酒风味的蜂蜜精酿含汽发酵酒及其制备方法 | |
CN106421519A (zh) | 一种保健药酒 | |
CN106036269A (zh) | 一种含南瓜酵素的饮料及其制备方法 | |
CN110771764A (zh) | 一种茉莉花香醋饮料的制备方法 | |
KR101067251B1 (ko) | 산양산삼을 함유하는 조성물 및 구증구포(九蒸九曝)를 이용하여 이를 제조하는 방법 | |
CN110804518A (zh) | 一种茉莉花香酒的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20071212 |